Epidemiological data in
Vietnam shows high HIV prevalence rates among injection drug users, especially
in urban centres. However, there are limited data on specific practices used to
prepare and inject drugs or on sexual practices among Vietnamese injectors. A
street-based cross-sectional interview was conducted with 862 heroin injectors
in Hanoi, Vietnam, to collect such data. Variability was seen in both injection
and sexual risk, with 12.9% of current injectors reporting at least one unsafe
method of drug sharing and 57.1% reporting unsafe sex in the past 30 days.
These risks were strongly associated with those who engaged in unsafe injection
significantly more likely to engage in unsafe sex (69.4% vs. 55.3%) and those
engaging in unsafe sex significantly more likely to engage in unsafe injection
(15.7% vs. 9.2%). These findings highlight the overlap of injection and sexual
risk practices among Vietnamese heroin users and suggest the need for strong,
broadly targeted HIV prevention activities among this population.
First heroin use – age | n | |
Mean | 862 | 18.5 |
Range | 11–27 | |
First heroin use – mode of administration | n | % |
Smoked | 802 | 93.0% |
Sniffed | 3 | 0.3% |
Injection | 57 | 6.6% |
First use – reason for using | n | % |
Curiosity | 459 | 53.3% |
Wanted to get high | 142 | 16.5% |
Friends encouraged me | 681 | 79.1% |
Sex partner encouraged me | 20 | 2.3% |
Drug dealer encouraged me | 22 | 2.6% |
Other | 127 | 14.8% |
Time between initiation (smoking) and first injection | n | % |
One month or less | 29 | 3.6% |
One month to one year | 157 | 19.6% |
More than one year | 616 | 76.8% |
First heroin injection – age | n | |
Mean | 856 | 20.9 |
Range | 11–29 | |
First drug ever used to get high | n | % |
Marijuana | 16 | 1.9% |
MDMA (Ecstasy) | 4 | 0.5% |
Amphetamine/methamphetamine | 7 | 0.8% |
Cocaine | 2 | 0.2% |
Morphine (Dolargan) | 4 | 0.5% |
Valium (Seduxen) | 2 | 0.2% |
Opium | 120 | 13.9% |
Heroin | 707 | 82.0% |
Ever used… | n | % |
Tobacco | 857 | 99.4% |
Alcohol | 765 | 88.7% |
Marijuana | 302 | 35.0% |
MDMA (Ecstasy) | 168 | 18.6% |
Amphetamine/methamphetamine | 298 | 34.6% |
Cocaine | 32 | 3.7% |
Morphine (Dolargan) | 106 | 12.3% |
Valium (Seduxen) | 290 | 33.6% |
Opium | 373 | 43.3% |
Ketamine | 16 | 1.9% |
Ever injected …(among those who ever used …) | n (never used) | % (of ever used) |
Amphetamine/methamphetamine | 45 (298) | 15.1% |
Cocaine | 4 (32) | 12.5% |
Morphine (Dolargan) | 2 (106) | 1.9% |
Valium (Seduxen) | 2 (290) | 0.7% |
Opium | 92 (373) | 24.7% |
Ketamine | 3 (16) | 18.8% |
Frequency of heroin use | ||
Daily | 707 | 82.0% |
Fewer than half the days | 64 | 7.4% |
Used more than once on last day used | 718 | 83.3% |
Numbers may not add up due to missing data; percentages have been adjusted to exclude missing data.
n | % | |
---|---|---|
Injected heroin | 862 | 67.9% |
Used syringe after someone else | 42 | 4.9% |
Gave used syringe to someone else | 58 | 6.7% |
Methods of drug division | ||
Frontloaded to/from used syringe | 44 | 5.1% |
Backloaded to/from used syringe | 6 | 0.7% |
Mixed in cooker, everyone drew | 25 | 2.9% |
Any syringe sharing/unsafe drug division | 111 | 12.9% |
Frontloaded to/from sterile syringe | 587 | 68.1% |
Backloaded to/from sterile syringe | 41 | 4.8% |
Divided dry, each person prepared own | 283 | 32.8% |
Any safe drug division | 737 | 85.5% |
Shared syringe with more than one other person (injectors who shared only, n = 76) | 49 | 64.4% |
Injection groups | ||
Usually inject alone | 317 | 36.8% |
Usually inject with different people (not same group) | 359 | 41.7% |
Usually inject with the same group | 185 | 21.5% |
Males | Females | |||
---|---|---|---|---|
n | % | n | % | |
Vaginal sex | ||||
Ever | 720 | 90.1% | 62 | 100% |
Within the past month (among ever) | 264 | 36.7% | 50 | 80.6% |
Within the past year (among ever) | 528 | 73.3% | 58 | 93.5% |
Receptive anal sex | ||||
Ever | 13 | 2.0% | 6 | 9.7% |
Within the past month (among ever) | 6 | 46.2% | 3 | 50.0% |
Within the past year (among ever) | 10 | 76.9% | 5 | 83.3% |
Insertive anal sex | ||||
Ever | 39 | 5.1% | Na | Na |
Within the past month | 16 | 41.0% | Na | Na |
Within the past year | 26 | 66.7% | Na | Na |
Last vaginal sex – age concordance | ||||
Partner was more than three years younger | 161 | 23.9% | 1 | 1.7% |
Partner was 1–2 years younger | 253 | 37.6% | 3 | 5.0% |
Partner was same age | 133 | 19.8% | 6 | 10.0% |
Partner was 1–2 years older | 57 | 8.5% | 12 | 20.0% |
Partner was more than three years older | 69 | 10.3% | 38 | 63.3% |
Last receptive anal sex – age concordance | ||||
Partner was more than three years younger | 1 | 8.3% | 0 | 0.0% |
Partner was 1–2 years younger | 0 | 0.0% | 0 | 0.0% |
Partner was same age | 2 | 16.7% | 0 | 0.0% |
Partner was 1–2 years older | 0 | 0.0% | 1 | 16.7% |
Partner was more than three years older | 9 | 75.0% | 5 | 83.3% |
Last insertive anal sex – age concordance | ||||
Partner was more than three years younger | 4 | 12.5% | Na | Na |
Partner was 1–2 years younger | 7 | 21.9% | Na | Na |
Partner was same age | 4 | 12.5% | Na | Na |
Partner was 1–2 years older | 3 | 9.4% | Na | Na |
Partner was more than three years older | 14 | 43.8% | Na | Na |
Condom use (among those who ever engaged in each specific practice) | ||||
Last vaginal sex | 297 | 41.3% | 30 | 48.4% |
Last receptive anal sex | 2 | 16.3% | 1 | 16.7% |
Last insertive anal sex | 18 | 46.2% | Na | Na |
Last vaginal sex work – client | Na | Na | 18 | 81.8% |
Last receptive anal sex work – client | 1 | 14.3% | 1 | 25.0% |
Last insertive anal sex work – subject | 4 | 36.4% | Na | Na |
Exchanged sex for money | ||||
Ever | 49 | 6.7% | 31 | 50.0% |
Last month | 37 | 75.5% | 27 | 87.1% |
Sex work last month | ||||
Mean number of times (range) | 9.1 (1–50) | 31.2 (1–99) | ||
Mean number of partners (range) | 6.3 (1–40) | 25.9 (1–60) |
Purchase full article at: http://goo.gl/aMgGng
By: Goldsamt LA1, Clatts MC2, Le G3, Yu G1.
- 1College of Nursing (https://nursing.nyu.edu/), New York University, New York, NY, USA.
- 2School of Public Health, University of Puerto Rico, San Juan, Puerto Rico.
- 3Center for Research and Training on HIV/AIDS, Hanoi Medical University, Hanoi, Vietnam.
- Drugs (Abingdon Engl). 2015 Apr;22(2):166-172.
More at: https://twitter.com/hiv insight
No comments:
Post a Comment